Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration

Patients with non-valvular atrial fibrillation (NVAF) exhibit a high risk of stroke, which is associated with high mortality. Thus, stroke prevention is crucial for the overall management of NVAF. Two categories of drugs, vitamin K antagonist warfarin and non-vitamin K antagonist oral anticoagulants...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shujuan, Hong, Xuejiao, Cao, Jingjing, Cai, Haixia, Du, Song, Ma, Peizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468491/
https://www.ncbi.nlm.nih.gov/pubmed/32973522
http://dx.doi.org/10.3389/fphar.2020.01293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468491/
https://www.ncbi.nlm.nih.gov/pubmed/32973522
http://dx.doi.org/10.3389/fphar.2020.01293

Ejemplares similares